专注于制药业务、目前市值816万美元的ProPhase Labs, Inc.宣布进行高管层变动，现任首席运营官 (COO) Jed Latkin即将离职，Stuart Hollenshead将接任新COO一职。此次人事变动紧随Pharmaloz Manufacturing, ...

ProPhase Labs, Inc., a company specializing in pharmaceutical preparations with a current market capitalization of $8.16 million, has announced an executive shift with the departure of its current ...

对于ProPhase Labs来说,这是充满挑战的一年。目前公司市值仅为1000万美元,股价已跌至52周新低,触及0.41美元。这一显著下跌反映出过去一年股价惊人的-91.19%跌幅。根据 InvestingPro 分析,该公司正在快速消耗现金,同时背负着大量债务。投资者担忧地看着ProPhase ...

In a challenging year for ProPhase Labs, now valued at just $10 million in market cap, the company's stock has plummeted to a 52-week low, touching down at $0.41. This significant downturn reflects a ...

ProPhase Labs, Inc. Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company’s Balance Sheet and ...

The Company will review with shareholders at 2:00 p.m. EST, details below.

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare ...

Stock analysts at StockNews.com initiated coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Free Report) in a research ...

Mitosis is conventionally divided into five stages known as prophase, prometaphase, metaphase, anaphase, and telophase. While mitosis is taking place, there is no cell growth and all of the ...

StockNews.com assumed coverage on shares of ProPhase Labs (NASDAQ:PRPH – Free Report) in a report released on Thursday. The firm issued a sell rating on the stock. ProPhase Labs Stock Performance ...